StonvexLoading…
StonvexStonvexStonvexCore line items from WEYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $68.00M | $276.17M | $199.37M | $126.25M |
Operating Income | $7.50M | $29.17M | $18.98M | $10.92M |
Net Income | $6.12M | $23.08M | $14.38M | $7.80M |
EPS (Diluted) | $0.64 | $2.41 | $1.50 | $0.81 |
Total Assets | $296.26M | $319.67M | $304.04M | $300.94M |
Total Liabilities | $52.62M | $80.10M | $52.72M | $52.87M |
Cash & Equivalents | $89.04M | $96.01M | $72.92M | $77.43M |
Free Cash Flow OCF − CapEx | $16.88M | $35.50M | $12.36M | $13.68M |
Shares Outstanding | 9.51M | 9.53M | 9.59M | 9.61M |